You are viewing a javascript disabled version of the site. Please enable Javascript for this site to function properly.
Go to headerGo to navigationGo to searchGo to contentsGo to footer
In content section. Select this link to jump to navigation

Technology and Health Care - Volume 30, issue 2

Purchase individual online access for 1 year to this journal.

Price: EUR 150.00
ISSN 0928-7329 (P)
ISSN  1878-7401 (E)
Impact Factor 2024: 1.4

Technology and Health Care is intended to serve as a forum for the presentation of original articles and technical notes, observing rigorous scientific standards. Furthermore, upon invitation, reviews, tutorials, discussion papers and minisymposia are featured. 

The following types of contributions and areas are considered:
 
1. Original articles:
Technology development in medicine: New concepts, procedures and devices associated with the use of technology in medical research and clinical practice are presented to a readership with a widespread background in engineering and/or medicine.

Significance of medical technology and informatics for healthcare: The appropriateness, efficacy and usefulness deriving from the application of engineering methods, devices and informatics in medicine and with respect to public health are discussed.

2. Technical notes:
Short communications on novel technical developments with relevance for clinical medicine.

3. Reviews and tutorials (upon invitation only):
Tutorial and educational articles for persons with a primarily medical background on principles of engineering with particular significance for biomedical applications and vice versa are presented.

4. Minisymposia (upon invitation only):
Under the leadership of a Special Editor, controversial issues relating to healthcare are highlighted and discussed by various authors.

results per page

Biotech value chain and technologies for COVID-19 research areas for collaboration on cost quality tradeoff with tool companies

Authors: Huttin, Christine C.

Article Type: Short Communication

Abstract: BACKGROUND: Technologies for COVID-19 are in high demand, and supply chains from biotech and pharma industries face critical supply issues. OBJECTIVE: This paper discusses the case on mRNA technologies and quality assurance issues. METHODS: Interviews with managers of biotech companies were performed. These helped to prepare biotech panels at a roundtable on quality of medicine, organized by the Polish Academy of Sciences in Paris (PAN) in 2021. RESULTS: This paper analyzes the new mRNA technology and shows the importance of emerging new biotech firms, especially tool companies providing services in … Show more

Keywords: Biotech value chain, tool companies, mRNA technology, cost and quality, COVID-19, healthcare

DOI: 10.3233/THC-213297

Citation: Technology and Health Care, vol. 30, no. 2, pp. 513-516, 2022

Get PDF
Show more